Bayesian Capital Management, LP - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$374,423
+20.0%
62,300
+19.3%
0.06%
-5.2%
Q2 2022$312,000–52,200–0.06%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders